A citation-based method for searching scientific literature

Emil Villiam Holm-Rasmussen, Maj-Britt Jensen, Eva Balslev, Niels Kroman, Tove Filtenborg Tvedskov. Breast 2018
Times Cited: 10







List of co-cited articles
31 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Ashleigh M Francis, Christine E Haugen, Lynn M Grimes, Jaime R Crow, Min Yi, Elizabeth A Mittendorf, Isabelle Bedrosian, Abigail S Caudle, Gildy V Babiera, Savitri Krishnamurthy,[...]. Ann Surg Oncol 2015
40
50

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
L M van Roozendaal, B Goorts, M Klinkert, K B M I Keymeulen, B De Vries, L J A Strobbe, C A P Wauters, Y E van Riet, E Degreef, E J T Rutgers,[...]. Breast Cancer Res Treat 2016
38
50

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
205
40


Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
185
30

Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
Ah Young Park, Hye Mi Gweon, Eun Ju Son, Miri Yoo, Jeong-Ah Kim, Ji Hyun Youk. Eur J Radiol 2014
31
30

Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review.
C H M van Deurzen, M G G Hobbelink, R van Hillegersberg, P J van Diest. Eur J Cancer 2007
29
30

Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
Cathelijne Heymans, James van Bastelaar, Ruben G J Visschers, Yvonne L J Vissers. Clin Breast Cancer 2017
10
30

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
372
30

Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.
Susan Prendeville, Ciara Ryan, Linda Feeley, Fionnuala O'Connell, Tara Jane Browne, Martin J O'Sullivan, Michael W Bennett. Breast 2015
24
30

Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
Yusuke Watanabe, Keisei Anan, Michiyo Saimura, Kenichiro Koga, Minoru Fujino, Mari Mine, Sadafumi Tamiya, Kazuyoshi Nishihara, Toru Nakano, Shoshu Mitsuyama. Breast Cancer 2018
12
30

Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified?
Luca Sorrentino, Alessandra Sartani, Daniela Bossi, Rosella Amadori, Manuela Nebuloni, Marta Truffi, Matteo Bonzini, Eliana Riggio, Diego Foschi, Fabio Corsi. Breast J 2018
7
42

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Gary H Lyman, Mark R Somerfield, Linda D Bosserman, Cheryl L Perkins, Donald L Weaver, Armando E Giuliano. J Clin Oncol 2017
207
30

Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Mary F Dillon, Enda W McDermott, Cecily M Quinn, Ann O'Doherty, Niall O'Higgins, Arnold D K Hill. J Surg Oncol 2006
73
20

An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Caren Wilkie, Laura White, Elisabeth Dupont, Alan Cantor, Charles E Cox. Am J Surg 2005
93
20

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.
Tomo Osako, Takuji Iwase, Masaru Ushijima, Rie Horii, Yasuyoshi Fukami, Kiyomi Kimura, Masaaki Matsuura, Futoshi Akiyama. Cancer Sci 2014
26
20

Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Emma J Groen, Lotte E Elshof, Lindy L Visser, Emiel J Th Rutgers, Hillegonda A O Winter-Warnars, Esther H Lips, Jelle Wesseling. Breast 2017
77
20

Current approach and future perspective for ductal carcinoma in situ of the breast.
Chizuko Kanbayashi, Hiroji Iwata. Jpn J Clin Oncol 2017
35
20


Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
196
20

Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Hyung Seok Park, Seho Park, Junghoon Cho, Ji Min Park, Seung Il Kim, Byeong-Woo Park. J Surg Oncol 2013
45
20

Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Jisun Kim, Wonshik Han, Jong Won Lee, Jee-Man You, Hee-Chul Shin, Soo Kyung Ahn, Hyeong-Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park,[...]. Breast 2012
43
20

The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Emil Villiam Holm-Rasmussen, Maj-Britt Jensen, Eva Balslev, Niels Kroman, Tove Filtenborg Tvedskov. Eur J Cancer 2017
11
20


Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Haruru Kotani, Akiyo Yoshimura, Yayoi Adachi, Junko Ishiguro, Tomoka Hisada, Mari Ichikawa, Naomi Gondou, Masaya Hattori, Naoto Kondou, Masataka Sawaki,[...]. Breast Cancer 2016
7
28

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
225
20

Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?
B Doyle, M Al-Mudhaffer, M M Kennedy, A O'Doherty, F Flanagan, E W McDermott, M J Kerin, A D Hill, C M Quinn. J Clin Pathol 2009
30
20

Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
Mattia Intra, Nicole Rotmensz, Paolo Veronesi, Marco Colleoni, Simona Iodice, Giovanni Paganelli, Giuseppe Viale, Umberto Veronesi. Ann Surg 2008
85
20


Upgrade of ductal carcinoma in situ on core biopsies to invasive disease at final surgery: a retrospective review across the Scottish Breast Screening Programme.
Y T Sim, J Litherland, E Lindsay, P Hendry, K Brauer, H Dobson, C Cordiner, T Gagliardi, L Smart. Clin Radiol 2015
14
20

Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
Yoon Joo Shin, Sun Mi Kim, Bo La Yun, Mijung Jang, Bohyoung Kim, Soo Hyun Lee. J Ultrasound Med 2019
6
33

Topographical, morphological and immunohistochemical characteristics of carcinoma in situ of the breast involving sclerosing adenosis. Two distinct topographical patterns and histological types of carcinoma in situ.
Suzuko Moritani, Shu Ichihara, Masaki Hasegawa, Tokiko Endo, Mikinao Oiwa, Misaki Shiraiwa, Chikako Nishida, Takako Morita, Yasuyuki Sato, Takako Hayashi,[...]. Histopathology 2011
11
10

Abnormal regulation of the oestrogen receptor in benign breast lesions.
B S Shoker, C Jarvis, R B Clarke, E Anderson, C Munro, M P Davies, D R Sibson, J P Sloane. J Clin Pathol 2000
52
10

Detection of occult invasion in ductal carcinoma in situ of the breast with sentinel node metastasis.
Tomo Osako, Takuji Iwase, Kiyomi Kimura, Rie Horii, Futoshi Akiyama. Cancer Sci 2013
13
10


When is a diagnosis of sclerosing adenosis acceptable at core biopsy?
Harmindar K Gill, Olga B Ioffe, Wendie A Berg. Radiology 2003
30
10

Sclerosing adenosis: Ultrasonographic and mammographic findings and correlation with histopathology.
Ya-Ling Chen, Jia-Jian Chen, Cai Chang, Yi Gao, Jiong Wu, Wen-Tao Yang, Ya-Jia Gu. Mol Clin Oncol 2017
10
10

Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence.
Atsushi Yoshida, Naoki Hayashi, Futoshi Akiyama, Hideko Yamauchi, Takashi Uruno, Mari Kikuchi, Hiroshi Yagata, Koichiro Tsugawa, Koyu Suzuki, Seigo Nakamura,[...]. Clin Breast Cancer 2012
11
10

Benign mechanical transport of breast epithelial cells to sentinel lymph nodes.
Nils M Diaz, Charles E Cox, Mark Ebert, John D Clark, Vesna Vrcel, Nicholas Stowell, Anu Sharma, James W Jakub, Alan Cantor, Barbara A Centeno,[...]. Am J Surg Pathol 2004
60
10


Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.
Lee Gravatt Wilke, Linda M McCall, Katherine E Posther, Pat W Whitworth, Douglas S Reintgen, A Marilyn Leitch, Sheryl G A Gabram, Anthony Lucci, Charles E Cox, Kelly K Hunt,[...]. Ann Surg Oncol 2006
373
10

Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
P J Borgstein, R Pijpers, E F Comans, P J van Diest, R P Boom, S Meijer. J Am Coll Surg 1998
568
10

The sentinel node in breast cancer--a multicenter validation study.
D Krag, D Weaver, T Ashikaga, F Moffat, V S Klimberg, C Shriver, S Feldman, R Kusminsky, M Gadd, J Kuhn,[...]. N Engl J Med 1998
10

Results of 23,810 cases of ductal carcinoma-in-situ.
William E Sumner, Leonidas G Koniaris, Sarah E Snell, Seth Spector, Jodeen Powell, Eli Avisar, Frederick Moffat, Alan S Livingstone, Dido Franceschi. Ann Surg Oncol 2007
48
10

Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann. Arch Surg 2010
54
10

A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Takafumi Kondo, Naoki Hayashi, Sachiko Ohde, Koyu Suzuki, Atsushi Yoshida, Hiroshi Yagata, Naoki Niikura, Takayuki Iwamoto, Kumiko Kida, Michiko Murai,[...]. J Surg Oncol 2015
24
10

Prognostic classification of breast ductal carcinoma-in-situ.
M J Silverstein, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon. Lancet 1995
505
10

Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
R J Jackman, F Burbank, S H Parker, W P Evans, M C Lechner, T R Richardson, A A Smid, H B Borofsky, C H Lee, H M Goldstein,[...]. Radiology 2001
251
10

Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy.
S M Feldman, D N Krag, R K McNally, B B Moor, D L Weaver, P Klein. J Am Coll Surg 1999
122
10

Are malignant cells displaced by large-gauge needle core biopsy of the breast?
L K Diaz, E L Wiley, L A Venta. AJR Am J Roentgenol 1999
135
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.